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Novelty and Impact 
Laboratory studies suggest that coffee and tea may protect against melanoma; however, 
epidemiological findings are inconsistent. We found an inverse association between caffeinated 
coffee consumption and melanoma risk among men, but not among women, and no association with 
decaffeinated coffee or tea consumption, in the European Prospective Investigation into Cancer and 
Nutrition (EPIC). Melanoma has a high disease burden and coffee is a widely consumed beverage, 
therefore our findings may have important public health implications.  
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Abstract  
In vitro and animal studies suggest that bioactive constituents of coffee and tea may have 
anticarcinogenic effects against cutaneous melanoma, however epidemiological evidence is limited 
to date. We examined the relationships between coffee (total, caffeinated or decaffeinated) and tea 
consumption and risk of melanoma in the European Prospective Investigation into Cancer and 
Nutrition (EPIC). EPIC is a multi-centre prospective study that enrolled over 500,000 participants 
aged 25-70 years from ten European countries in 1992-2000. Information on coffee and tea drinking 
was collected at baseline using validated country-specific dietary questionnaires. We used adjusted 
Cox proportional hazards regression models to calculate hazard ratios (HR) and 95% confidence 
intervals (95% CI) for the associations between coffee and tea consumption and melanoma risk. 
Overall, 2,712 melanoma cases were identified during a median follow-up of 14.9 years among 
476,160 study participants. Consumption of caffeinated coffee was inversely associated with 
melanoma risk among men (HR for highest quartile of consumption vs. non-consumers 0.31, 95% 
CI 0.14-0.69) but not among women (HR 0.96, 95% CI 0.62-1.47). There were no statistically 
significant associations between consumption of decaffeinated coffee or tea and the risk of 
melanoma among both men and women. The consumption of caffeinated coffee was inversely 
associated with melanoma risk among men in this large cohort study. Further investigations are 
warranted to confirm our findings and clarify the possible role of caffeine and other coffee 
compounds in reducing the risk of melanoma. 
 
Word count: 3,528 
Abstract word count: 235
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Introduction  
The age-standardized incidence of cutaneous melanoma has been increasing for decades 
worldwide, although it has shown a tendency to stabilization in high-incidence countries in recent 
years [1]. In 2012, there were an estimated 232,000 new cases of cutaneous melanoma and 55,000 
related deaths globally [2]. The most affected world regions are those inhabited by white 
populations of European descent, with incidence being highest in Oceania, Northern America and 
Northern Europe and lowest in Africa, Southern America and Asia [2].  
The main established risk factor for cutaneous melanoma is exposure to ultraviolet (UV) 
radiation. In particular, the risk of developing a cutaneous melanoma depends in a complex way on 
the interplay between the patterns of exposure to UV radiation (acute/intermittent or chronic 
exposure to sunlight, history of sunburns, use of sunbeds and sunlamps) and the individual 
susceptibility to disease (people with fair complexion, red or blonde hair, blue eyes, many naevi and 
freckles are at higher risk) [3-5]. Several other exposures have been investigated as possible risk or 
preventive factors for melanoma occurrence, and some evidence exists that overweight and obesity 
[6], adult height [7] and alcohol drinking [8] are positively associated with melanoma risk. 
In vitro and animal studies have shown that caffeine and other constituents of coffee and tea 
influence several biological processes implicated in carcinogenesis, including DNA methylation, 
oxidative damage and apoptosis [9-12]. In particular, caffeine can inhibit UV-induced 
carcinogenesis through a number of complementary biological mechanisms [13], and black tea 
polyphenols can induce apoptosis of melanoma cell lines in vitro [14]. The hypothesis that coffee 
and tea consumption is protective against melanoma has been tested in several epidemiological 
studies, with conflicting results [15-20]. Despite some evidence of an inverse association between 
consumption of caffeinated coffee and melanoma risk, the question still remains unresolved as it 
has been examined in only a limited number of prospective studies with accurate collection of 
dietary habits and long enough follow-up. Hence, in the present study we aimed to examine the 
This article is protected by copyright. All rights reserved.
  8
relationships between consumption of coffee (total, caffeinated or decaffeinated) and tea and the 
risk of melanoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). 
 
Materials and Methods  
Study population 
EPIC is a multi-centre prospective cohort study that investigates the role of dietary, lifestyle, 
genetic and environmental factors in the aetiology of cancer and other chronic diseases. The 
methodology and rationale of the EPIC study have been described elsewhere [21-22]. Briefly, 
521,324 participants mostly aged 25-70 years were recruited during 1992-2000 in 23 centres from 
10 European countries (France, Italy, Spain, United Kingdom, the Netherlands, Greece, Germany, 
Sweden, Denmark and Norway). Most study participants were selected from the general population, 
with some exceptions: the French cohort recruited female members of a health insurance scheme 
for school and university employees; the Utrecht cohort in the Netherlands was based on women 
participating in the local breast cancer screening programme; the cohorts in Ragusa and Turin 
(Italy) and in the Spanish centres partly consist of blood donors; and the Oxford cohort in the 
United Kingdom consists predominantly of vegetarians and “health conscious” volunteers. Only 
female participants were recruited in Norway, France, Naples (Italy) and Utrecht (The Netherlands). 
Approval for the EPIC study was obtained from the Ethical Review Board of the International 
Agency for Research on Cancer (IARC) and the local Ethics Committees relevant for each study 
centre. All study participants provided signed informed consent before study entry.  
For this study, we excluded study participants with prevalent cancers (n = 25,184); with 
missing or insufficient follow-up information (n = 4,148); with missing information on any of 
lifestyle factors, diet (including coffee and tea drinking) or anthropometry (n = 6,259); and those in 
the top or bottom 1% of the ratio of energy intake to energy expenditure (n = 9,573). Finally, the 
dataset for this analysis included 476,160 study participants. 
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Exposure assessment 
Dietary intakes over the 12 months before recruitment were recorded at baseline by using 
validated country-specific dietary questionnaires. Questionnaires were usually self-administered, 
except in Spain, Greece and Ragusa (Italy), where the dietary questionnaire was filled in by a 
trained interviewer. In Malmö (Sweden), a short food-frequency questionnaire was combined with a 
7-day dietary diary. The structure of questions varied somewhat across centres: data on tea 
consumption was not available for Norway; data on consumption of caffeinated and decaffeinated 
coffee was not available in Naples and Ragusa (Italy), Umeå (Sweden), Denmark and (only for 
decaffeinated coffee) Norway and Malmö (Sweden). The recorded number of cups of coffee (any 
type, caffeinated or decaffeinated) and tea per month, week and day was translated into daily 
consumptions (mL/day). 
Data on lifestyle factors were collected using gender-specific questionnaires common to all 
study centres, which included questions on smoking habits and alcohol consumption, education, 
occupation, medical history, occupational, household and leisure-time physical activity, and (for 
women) menstrual and reproductive history and use of exogenous sex hormones (oral 
contraceptives and hormone replacement therapy). More details on both questionnaires can be 
found elsewhere [22]. Height and weight were measured at recruitment by trained health 
professionals, except in France, Oxford (United Kingdom), and Norway, where self-reported 
measurements were obtained.  
 
Follow-up and endpoints 
The identification of incident cancers and vital status follow-up were conducted using a 
combination of methods including linkage with population cancer and pathology registries, health 
insurance and hospital discharge records, national and regional mortality registries, and active 
follow-up through study subjects and their next-of-kin. Incident cancers were coded according to 
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the International Classification of Diseases-Oncology (ICD-O), 3rd edition. The outcome of the 
present analysis was melanoma, which corresponds to the codes 8720-8790 for morphology (with 2 
or 3 as 5th digit for in situ and invasive malignancies, respectively); both cutaneous and extra-
cutaneous melanomas were included in the analysis.  
 
Statistical analysis 
We calculated hazard ratios (HR) and 95% confidence intervals (95% CI) for the 
associations between the consumption of coffee (any type, caffeinated or decaffeinated) and tea and 
the risk of melanoma among male and female participants, by using Cox proportional hazards 
regression models with age as time scale and EPIC-participating centre and age at recruitment (in 1-
year intervals) as stratifying variables. Person-time at risk was calculated from the date of 
recruitment until the date of first incident cancer (except for non-melanoma skin cancers), death, 
emigration, date of last contact, or end of follow-up (from June 2008 to December 2013, depending 
on centre), whichever occurred first. Participants diagnosed with melanoma after the censoring date 
(for instance, melanoma diagnosed as second primary malignancy) were considered non-cases. The 
proportional hazards assumption was checked by testing for a non-zero slope in a regression of the 
scaled Schonfeld residuals on functions of time [23].  
Previous research suggested that the association between coffee consumption and melanoma 
risk may vary with gender [16,19]. In addition, there is much diversity between countries regarding 
the patterns of consumption of coffee and tea [24-26]. Therefore, coffee and tea consumption were 
entered into the models using sex- and country-specific categories of intake: non-consumers were 
considered as the category of reference, and consumers were categorized into quartiles (for coffee, 
caffeinated coffee and tea) or tertiles (for decaffeinated coffee, due to the large number of non-
consumers). Linear trends across categories of consumption were evaluated by entering the median 
value of each category of consumption as a continuous term in the model. Additional models were 
fitted using study-wide (instead of country- and sex-specific) categories of intake, or with the 
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consumption of each beverage entered as a continuous variable (HR calculated per 100 mL/day 
increase).  
All models were adjusted for variables considered a priori to be potential confounders of the 
association between coffee consumption and melanoma risk, namely educational level (considered 
as a proxy of socioeconomic status; none, primary school, technical/professional school, secondary 
school, university or higher degree); body mass index (BMI; <25, 25-29.9, ≥30 kg/m2); smoking 
status (never, former, current); alcohol drinking (non drinker; low intake: men >0-6 g/day, women 
>0-3 g/day; moderate intake: men >6-12 g/day, women >3-12 g/day; high intake: >12 g/day); and 
recreational physical activity levels (country- and sex-specific quartiles of metabolic equivalent 
[MET]-hours/week). In addition, we also adjusted for total energy intake (continuous), consumption 
of food groups (vegetables, fruits, red meat, poultry and fish; continuous) and estimated dietary 
intakes (estimated from food-frequency questionnaires) of beta-carotene, vitamin D (in µg) and 
vitamin C (in mg) (continuous). Models among women were adjusted for menopausal status at 
recruitment (premenopausal, perimenopausal, postmenopausal), age at menarche (continuous), age 
at first full-term pregnancy (continuous), and ever use of oral contraceptives (yes/no) or 
menopausal hormone therapy (yes/no) as well. Models for coffee (any type) and tea were adjusted 
for one another; models assessing caffeinated and decaffeinated coffee separately were adjusted for 
one another and for consumption of tea.  
Additional analyses were conducted for melanoma belonging to different histological types 
(superficial spreading, nodular, and lentigo maligna melanoma) and occurring on different body 
sites (head and neck, trunk, upper limb, and lower limb). Heterogeneity of associations across 
categories of educational level, smoking status, alcohol drinking, and BMI were tested by adding 
multiplicative interaction terms to the models and using the likelihood ratio tests for interaction. We 
finally performed a range of sensitivity analyses by excluding extra-cutaneous melanomas, in situ 
melanomas, or incident cancers that were diagnosed during the first 12 months of follow-up (in 
order to evaluate whether preclinical disease may have influenced the results).  
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Statistical analyses were conducted using Stata version 14 (Stata Corp, College Station, TX). 
All statistical tests were two-sided, and p-values of less than 0.05 were considered as statistically 
significant.  
 
Results 
Overall, 2,712 melanoma cases (including 221 in situ melanomas, 8.1%) were identified 
during a median follow-up of 14.9 years. The majority were cutaneous melanomas (n = 2,557, 
94.3%): the most frequent localizations were the lower limbs (30.8%) and the trunk (30.4%), 
followed by the upper limbs (20.4%) and the head and neck (13.2%); 1.4% were melanomas of 
overlapping sites of skin, and no information on skin site was available for 3.8% of cutaneous 
melanomas. Extra-cutaneous melanomas were 122 (4.5%), of which 77 were ocular melanomas; the 
primary melanoma site was unknown for 33 melanomas (1.2%). Information on morphology was 
available for 68.8% of cases: the superficial spreading histological type accounted for 69.4% of 
these, 12.3% were nodular melanomas, 11.4% were lentigo maligna melanomas, and 6.9% 
belonged to other histological types.  
Numbers of study participants and melanoma cases, person-years, proportion of non-
consumers, and the median and 10th-90th percentiles of consumption of coffee and tea by country 
are shown in Table 1. Melanoma incidence rate was highest in Denmark (58 cases per 100,000 
person-years) and lowest in Greece (10 cases per 100,000 person-years). Daily consumption of 
coffee and tea varied substantially across countries. The proportion of coffee non-consumers ranged 
between 3.7% (in Denmark and United Kingdom) and 14.7% (in France, only female participants). 
Among coffee drinkers, the lowest and highest reported consumption were in Italy (median 92 
mL/day) and Denmark (median 900 mL/day), respectively. Caffeinated coffee as a proportion of 
total coffee consumption ranged between 73.6% (in United Kingdom) and 95.8% (in Italy). 
Consumption of tea was lowest in Greece (median <1 mL/day) and highest in United Kingdom 
(median 475 mL/day).  
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Baseline characteristics of study participants according to consumption of coffee and tea are 
presented in Table 2. Study participants in the top quartile of coffee consumption were more 
frequently of male gender, slightly younger, more likely to be smokers and to drink alcohol, more 
physically active, and reported a higher energy intake, a lower consumption of fruit, vegetables and 
fish, and a higher consumption of red meat, compared to coffee non-consumers. Female participants 
in the top quartile of coffee consumption were also more likely to be pre-menopausal and have ever 
used oral contraceptives than coffee non-consumers. Tea consumers in the top quartile had a lower 
BMI, were more highly educated, less likely to be smokers but more likely to drink alcohol, were 
more physically active, reported a lower intake of fruit, red meat, poultry and fish, and a higher 
intake of β-carotene, compared to tea non-consumers. Female tea drinkers were more likely to have 
ever used oral contraceptives and menopausal hormone therapy than non-drinkers.  
We found a statistically significant inverse association between consumption of coffee and 
melanoma risk among men (HR for study participants in the 4th quartile of consumption vs. non-
consumers 0.47, 95% CI 0.23-0.94, p for trend = 0.001), but not among women (HR 1.10, 95% CI 
0.70-1.72, p for trend = 0.598) (p for heterogeneity <0.0001) (Table 3). The HR in linear models 
including coffee consumption by 100 mL/day was 0.95 (95% CI 0.92-0.98, p = 0.001) among men 
and 1.01 (95% CI 0.98-1.04, p = 0.471) among women. The inverse association between coffee and 
melanoma risk among men was driven by the consumption of caffeinated coffee (HR 0.31, 95% CI 
0.14-0.69, p for trend = 0.001); instead, the consumption of decaffeinated coffee was not 
statistically significantly associated with melanoma risk (Table 4). There were no statistically 
significant associations between consumption of tea and melanoma risk among neither men (HR 
1.18, 95% CI 0.72-1.94, p for trend = 0.940) nor women (HR 0.82, 95% CI 0.56-1.21, p for trend = 
0.401). 
The association between the consumption of caffeinated coffee and melanoma risk varied 
somewhat across histological types among men: the HR for a 100 mL/day higher consumption of 
caffeinated coffee was 0.86 (95% CI 0.75-0.98, p = 0.021) for superficial spreading melanoma, 0.95 
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(95% CI 0.77-1.18, p = 0.651) for nodular melanoma, and 0.83 (95% CI 0.69-1.01, p = 0.061) for 
lentigo maligna melanoma. Concerning body sites, the corresponding HR was 0.56 (95% CI 0.34-
0.91, p = 0.020) for melanoma of head and neck, 0.85 (95% CI 0.76-0.96, p = 0.008) for melanoma 
of the trunk, 1.01 (95% CI 0.86-1.19, p = 0.899) for melanoma of the upper limb, and 0.73 (95% CI 
0.47-1.13, p = 0.154) for melanoma of the lower limb. There was no association between 
consumption of caffeinated coffee and risk of melanoma of any histological type and at any body 
site among women. 
The results were only marginally affected by the exclusion of in-situ and extra-cutaneous 
melanomas and melanomas of unknown primary site (n = 374), or by the exclusion of melanomas 
diagnosed within the first 12 months of cohort inception (n = 146). The use of study-wide instead of 
country- and sex-specific categories of beverages consumption did not alter the results either. We 
found no evidence that the relationship between consumption of caffeinated coffee and melanoma 
risk varied by educational level, smoking habits, alcohol intake, reproductive history, use of 
exogenous hormones, or BMI at study recruitment. We found no departures from the proportional 
hazards assumption of Cox models.  
 
Discussion 
In this large prospective multi-centre cohort study, the consumption of caffeinated coffee 
was inversely associated with melanoma risk among men, with some variability across different 
histological types and body sites. The reduction in melanoma risk among men was 10% for a linear 
increase in the consumption of caffeinated coffee by 100 mL/day, and 70% for those in the top 
country-specific quartile of consumption. We found no association between the consumption of 
caffeinated coffee and melanoma risk among women; likewise, the consumption of decaffeinated 
coffee or tea was not associated with melanoma risk among both male and female study 
participants. Results were robust with respect to model specifications and across a range of 
sensitivity analyses. 
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Our results point towards caffeine as the most plausible factor explaining the inverse 
association between coffee consumption and melanoma risk. This view is supported by 
experimental studies conducted on animal models and human tumour cells. In mice, the oral 
administration of caffeine has a sunscreen effect by inhibiting the dimerization of adjacent 
thymidine residues typically induced by UVB radiation [13,27], and may enhance apoptosis of 
damaged pre-cancerous cells through several complementary biological mechanisms, both p53-
dependent and p53-independent [13,28-29]. In human melanoma cells, caffeine can inhibit the 
activation of transcription factors involved in the response to UVB exposure [30]; oppose cell 
growth and induce cell differentiation [31]; and prevent cell adhesion to the extracellular matrix, 
thereby reducing cell invasion and migration and ultimately the formation of distant metastasis [32-
34].  
The association between coffee drinking and melanoma risk had been investigated in only a 
few prospective cohorts prior to our study. No association between consumption of coffee (any 
type, filtered or boiled) and melanoma risk emerged in the Västerbotten Intervention Project cohort 
in Sweden [17]. Likewise, there was no evidence of an effect of coffee drinking on melanoma risk 
among women enrolled in the Women’s Health Initiative Observational Study, except for a reduced 
risk among long-term coffee drinkers [18]. Instead, study participants in the highest category of 
coffee consumption in the US NIH-AARP (National Institutes of Health – American Association of 
Retired Persons) cohort had a lower melanoma risk compared to non-coffee drinkers [20]. Unlike 
our study, an inverse association between coffee consumption and melanoma risk was found among 
female members of a population-based cohort in Norway [16] and in the Nurses’ Health Study, 
while no association emerged among male participants of the Health Professional Follow-up Study 
[19]. In the Norwegian Women and Cancer Study, melanoma risk was inversely associated with 
filtered coffee consumption, while no association was observed for consumption of instant or boiled 
coffee [35]. When consumption of caffeinated and decaffeinated coffee was separately investigated, 
the latter was not associated with melanoma risk in any of the above cohorts. Remarkably, and in 
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contrast to our findings, the inverse association between caffeinated coffee and melanoma risk was 
limited to malignancies arising on body sites with continuous sun exposure (head, neck, and 
extremities) in the Nurses’ Health Study [19]. Finally, findings from prospective cohort studies are 
largely consistent with our finding of a null association between tea drinking and melanoma risk 
[15,18].  
The geographical variability in factors that affect the content and concentration of caffeine 
and other biologically active compounds taken with coffee (including the roasting, brewing and 
preparation methods, and the average cup size) [24-26] and some methodological differences (for 
example the detail with which the information is collected on the consumption of coffee and tea) 
may help explain why the inverse relationship between coffee consumption and melanoma risk 
could not be seen in all prospective studies published to date. It is more challenging to explain the 
disagreement between our findings and the studies that found an inverse association only among 
women [16,19]. Previous studies reported that coffee consumption patterns and melanoma risk are 
associated with socio-economic status (SES) [36-37]. These associations may vary between 
genders, geographically and over time, which may partly explain the inconsistency of results from 
studies conducted in different countries and enrolling study populations of different age. We 
adjusted all our estimates by educational level, a commonly used surrogate variable for SES; 
however, SES is an elusive concept to define and measure in epidemiological studies, thus some 
residual confounding cannot be excluded. 
Major strengths of our study are its prospective design, large sample size and long-term 
follow-up. The association between coffee and tea consumption and melanoma risk was associated 
in only a few European studies so far, while this study extends to a greater number of European 
populations. Exposure and covariates were assessed before melanoma diagnosis using validated 
questionnaires, thereby minimizing the likelihood of recall bias. The multicentre coverage of the 
EPIC study allowed examining a wide range of coffee and tea consumption patterns. Although no 
estimate of total caffeine intake (including sources other than coffee and tea) is available in the 
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EPIC study, coffee and tea are largely the predominant source of caffeine in all countries 
participating in the EPIC study [38]. We used country- and gender- specific quartiles (caffeinated 
coffee and tea) and tertiles (decaffeinated coffee) of consumption to reduce exposure 
misclassification, which might have diluted some of the associations; however, the use of cohort-
wide categories of consumption did not substantially affect the results. Our study has several 
limitations as well. No information was available on study participants’ phenotypic characteristics 
(like skin, hair and eye colour, freckling and naevus count). However, the use of models stratified 
by study centre should mitigate this limitation, as it is unlikely that there is a within-centre 
association between coffee and tea consumption and phenotypic risk factors for melanoma. We do 
not have any information on patterns of exposure to UV radiation either. However, in previous 
investigations, no association was reported between coffee consumption and behavioural risk 
factors for melanoma (except for sunscreen use) in the National Health and Nutrition Examination 
Survey (NHANES) in the US [20], and the adjustment for sunlight-related variables did not 
appreciably affect the association between coffee and tea consumption and the risk of melanoma in 
the Women’s Health Initiative Observational Study [18] and in the Norwegian Women and Cancer 
Study [35]. We lack information on the concentration of bioactive compounds (such as caffeine, 
polyphenols and diterpens) in coffee and tea, and on the many factors affecting it, such as the coffee 
brewing methods and the type (black or green) and preferred drinking temperature of coffee and 
tea, all of which vary greatly across European countries (with Northern populations drinking large 
quantities of fairly diluted coffee, and Southern populations consuming a comparatively smaller 
amount of strong coffee, like espresso). Furthermore, we only had data on consumption of coffee 
and tea at cohort enrolment, which prevented us from examining the link between the lifetime 
consumption of these beverages and melanoma risk. Finally, participating centres vary in their 
ability to capture and report in situ melanoma; however, the exclusion of the latter did not 
substantially affect the risk estimates. 
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In conclusion, we found an inverse association between caffeinated coffee drinking and 
melanoma risk among men, but not women, enrolled into the EPIC study. As melanoma has a high 
burden of disease among populations of European descent [2], and coffee and tea are among the 
most widely consumed drinks in European countries [39], our results, if confirmed, may have 
important public health implications. Further investigations are warranted to confirm our findings 
and clarify the possible role of caffeine and other coffee compounds in reducing the risk of 
melanoma.  
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Table 1. Distribution of study participants and melanoma cases, and consumption of coffee and tea, in countries participating to the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study.   
    Coffee consumption (mL/day)  Tea consumption (mL/day) 
Country Participants Person-years 
Melanoma 
cases 
Non 
consumers 
(%) 
Median (a) 10
th
-90th 
percentile (a)   
Non 
consumers 
(%) 
Median (a) 10
th
-90th 
percentile (a) 
Denmark 55,014 815,097 475 3.7 900 200-1600   16.1 200 3-900 
France 67,403 869,372 383 14.7 280 70-657  40.8 214 15-721 
Germany 48,557 504,479 192 4.3 400 103-870  24.0 53 2-450 
Greece 26,048 281,284 28 6.3 140 48-380  46.3 <1 <1-34 
Italy 44,545 630,951 160 8.9 92 37-189  45.0 43 5-150 
Norway (b) 33,975 452,171 219 9.0 420 120-780  - - - 
Spain 39,989 637,947 131 11.6 102 4-289  96.0 114 29-306 
Sweden 48,674 801,130 402 4.0 400 150-813  52.4 89 1-625 
The Netherlands 36,539 524,671 248 4.9 500 250-1000  10.4 237 27-594 
United Kingdom 75,416 1,122,765 474 3.7 380 4-857   2.7 475 2-1140 
Total 476,160 6,639,867 2,712 7.1 310 50-900   38.6 179 3-855 
 
(a)
 Medians and percentiles were calculated among consumers. 
(b)
 No information on tea consumption was available for Norway.  
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Table 2. Baseline characteristics of study participants according to levels of coffee and tea consumption in the European Prospective Investigation into 
Cancer and Nutrition (EPIC) study. 
   Coffee consumption  Tea consumption 
 Total population  Non-consumers 4th quartile  Non-consumers 4th quartile 
Participants (n) 476,160   33,814 98,740   149,810 33,975 
Women (%) 70.1  78.8 70.0  66.5 68.3 
Age (mean, SD) 51.2 (9.9)  51.7 (9.6) 49.9 (8.9)  52.7 (8.8) 51.9 (9.9) 
Body Mass Index (kg/m2) (a) 24.8 (22.4-27.8)  24.4 (21.8-27.7) 25.1 (22.6-28.0)  25.8 (23.1-28.9) 24.2 (22.0-26.9) 
Education (%)        
none/primary 31.1  33.4 31.7  48.5 19.1 
technical/secondary school 44.2  43.8 44.2  33.8 45.9 
university degree 24.7  22.8 24.1  17.7 35.0 
Smoking (%)        
never smoker 50.0  65.0 38.1  49.9 51.4 
former smoker 27.2  22.1 26.0  23.6 31.0 
current smoker 22.8  12.9 35.9  26.5 17.6 
Alcohol drinking at recruitment (%)        
- non drinker 13.4  31.0 12.6  21.7 10.2 
>0-6 gr/d (M) / >0-3 gr/d (F) 30.0  29.0 28.6  22.3 29.9 
>6-12 gr/d (M) / >3-12 gr/d (F) 26.0  19.9 26.4  21.5 27.2 
>12 gr/d 30.6  20.1 32.4  34.5 32.7 
Recreational physical activity (MET-hours/week) (a) 24 (12-42)  21 (10-39) 24 (12-42)  21 (9-38) 28 (15-48) 
Age at menarche (mean, SD) 13.1 (1.5)  13.1 (1.6) 13.0 (1.5)  13.0 (1.6) 13.1 (1.6) 
Age at first full-term pregnancy (mean, SD) 24.9 (4.3)  25.0 (4.3) 24.4 (4.4)  24.7 (4.2) 25.2 (4.4) 
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Menopausal status (%)        
premenopausal 34.8  32.3 38.1  31.0 32.6 
perimenopausal 19.1  21.3 20.9  18.7 18.7 
postmenopausal 46.1  46.4 41.0  50.3 48.7 
Ever use of oral contraceptives (%) 58.6  52.1 61.2  47.4 64.9 
Ever use of hormones for menopause (%) 25.9  24.7 25.6  22.6 30.5 
Total energy intake (kcal/day) (a) 1997 (1631-2436)  1973 (1590-2407) 2085 (1698-2549)  2077 (1691-2527) 2061 (1693-2500) 
Vegetables (g/day) (a) 175 (110-276)  199 (125-300) 179 (111-285)  188 (115-298) 184 (119-287) 
Fruit (g/day) (a) 201 (112-322)  235 (128-364) 193 (103-320)  232 (124-358) 198 (112-315) 
Red meat (g/day) (a) 35 (16-63)  34 (16-59) 39 (19-67)  41 (21-66) 37 (17-66) 
Poultry (g/day) (a) 15 (6-27)  16 (6-30) 16 (6-29)  18 (6-34) 13 (5-24) 
Fish (g/day) (a) 28 (14-50)  32 (16-55) 29 (15-51)  32 (16-54) 24 (12-41) 
β-carotene (µg/day) (a) 2864 (1817-4517)  3191 (1955-4924) 2854 (1784-4515)  2574 (1625-4102) 3378 (2126-5019) 
Vitamin D (µg/day) (a) 3.3 (2.2-5.0)  3.0 (2.0-4.6) 3.4 (2.3-5.2)  3.2 (2.0-5.1) 3.2 (2.2-4.6) 
Vitamin C (mg/day) (a) 114 (80-158)   120 (84-166) 112 (78-158)   119 (82-168) 117 (85-160) 
 
(a)
 Median value (interquartile range) 
SD: standard deviation 
MET: metabolic equivalent of task 
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Table 3. Hazard ratios (HR) and 95% confidence intervals (CI) for consumption of coffee (any type) and tea and risk of melanoma in the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study.   
  Men  Women 
Level of consumption   No. non-
cases 
No. cases HR (a) Lower 95% CI 
Upper 
95% CI p-value 
(b)
   
No. non-
cases 
No. cases HR (a) Lower 95% CI 
Upper 
95% CI p-value 
(b)
 
Coffee 
Non-consumers  7,119 46 1.00     26,521 128 1.00    
1st quartile  38,657 270 0.99 0.51 1.93   95,026 547 0.98 0.64 1.50  
2nd quartile  35,488 257 0.85 0.44 1.67   70,532 392 1.09 0.70 1.68  
3rd quartile  30,545 187 0.83 0.41 1.67   71,325 380 0.95 0.59 1.51  
4th quartile   29,524 148 0.47 0.23 0.94 0.001   68,711 357 1.10 0.70 1.72 0.598 
Increase by 100 mL/d   141,333 908 0.95 0.92 0.98 0.001   332,115 1,804 1.01 0.98 1.04 0.471 
Tea (c) 
Non-consumers  49,835 319 1.00     99,173 483 1.00    
1st quartile  30,322 167 1.06 0.68 1.64   58,681 293 0.88 0.62 1.26  
2nd quartile  18,661 122 1.07 0.66 1.74   53,393 330 0.86 0.60 1.23  
3rd quartile  25,969 179 0.92 0.59 1.43   51,385 283 1.08 0.75 1.53  
4th quartile   16,546 121 1.18 0.72 1.94 0.940   35,727 196 0.82 0.56 1.21 0.401 
Increase by 100 mL/d   141,333 908 1.00 0.96 1.04 0.978   298,359 1,585 0.99 0.95 1.02 0.365 
(a)
 Country- and sex-specific quantiles of consumption. Proportional hazards regression models stratified on study centre and age at recruitment. Consumptions of coffee and tea 
were adjusted for one another and for education, body mass index, smoking, alcohol intake, recreational physical activity, energy intake, consumption of main food groups 
(vegetables, fruits, red meat, poultry and fish), dietary intakes of beta-carotene, vitamin C and vitamin D, and (for women) menopausal status, age at menarche, age at first full-
term pregnancy, and ever use of oral contraceptives or menopausal hormone therapy.  
(b)
 Evaluated by entering the median value of each category of consumption in the model. 
(c)
 Information on tea consumption is not available in Norway.  
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Table 4. Hazard ratios (HR) and 95% confidence intervals (CI) for consumption of caffeinated and decaffeinated coffee and risk of melanoma in the 
European Prospective Investigation into Cancer and Nutrition (EPIC) study.   
  Men  Women 
Level of consumption   No. non-
cases 
No. cases HR (a) Lower 95% CI 
Upper 
95% CI p-value 
(b)
   
No. non-
cases 
No. cases HR (a) Lower 95% CI 
Upper 
95% CI p-value 
(b)
 
Caffeinated coffee (c) 
Non-consumers  24,969 113 1.00     65,980 272 1.00    
1st quartile  21,426 136 0.80 0.36 1.81   66,240 384 0.89 0.58 1.37  
2nd quartile  19,068 128 0.72 0.32 1.61   54,778 315 0.85 0.56 1.27  
3rd quartile  19,735 130 0.63 0.28 1.40   49,708 301 0.94 0.61 1.46  
4th quartile   15,309 78 0.29 0.12 0.69 <0.001   46,647 247 0.93 0.60 1.43 0.988 
Increase by 100 mL/d   100,507 585 0.89 0.83 0.85 0.001   283,353 1519 0.99 0.95 1.04 0.825 
Decaffeinated coffee (d) 
Non-consumers  57,430 260 1.00     141,725 608 1.00    
1st tertile  15,949 75 0.80 0.25 2.59   45,961 262 1.13 0.68 1.88  
2nd tertile  6,608 30 1.25 0.42 3.69   18,467 116 1.15 0.68 1.96  
3rd tertile   10,406 70 0.84 0.35 2.05 0.940   29,481 168 1.05 0.63 1.74 0.835 
Increase by 100 mL/d   90,393 435 0.88 0.75 1.04 0.133   235,634 1,154 0.99 0.91 1.08 0.853 
(a)
 Country- and sex-specific quantiles of consumption. Proportional hazards regression models stratified on study centre and age at recruitment. Consumptions of caffeinated and 
decaffeinated coffee were adjusted for one another, for consumption of tea, and for education, body mass index, smoking, alcohol intake, recreational physical activity, energy 
intake, consumption of main food groups (vegetables, fruits, red meat, poultry and fish), dietary intakes of beta-carotene, vitamin C and vitamin D, and (for women) menopausal 
status, age at menarche, age at first full-term pregnancy, and ever use of oral contraceptives or menopausal hormone therapy.  
(b)
 Evaluated by entering the median value of each category of consumption in the model. 
(c)
 Information on consumption of caffeinated coffee is not available in Naples and Ragusa (Italy), Umeå (Sweden) and Denmark. 
(d)
 Information on consumption of decaffeinated coffee is not available in Naples and Ragusa (Italy), Denmark, Norway and Sweden. 
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